By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Institute for Clinical Excellence (NICE) 

MidCity Place
71 High Holborn
London    WC1V 6NA  United Kingdom
Phone: 44-0-20-7067-5800 Fax: 44-0-20-7067-5801


SEARCH JOBS


Industry
Government

Segment
Research





Company News
PTC Therapeutics (PTCT) Release: National Institute for Clinical Excellence (NICE) Recommends Translarna (Ataluren) For The Treatment Of Patients With Nonsense Mutation Duchenne Muscular Dystrophy In England 4/15/2016 10:07:46 AM
Olympus Medical Systems Corp. Plasma Prostate Resection System Is Recommended By National Institute for Clinical Excellence (NICE) 3/30/2016 7:54:34 AM
National Institute for Clinical Excellence (NICE) Okays Medtronic (MDT) Veo System for Certain Type 1 Diabetics 2/12/2016 7:27:15 AM
Bristol-Myers Squibb (BMY) Release: National Institute for Clinical Excellence (NICE) Recommends Daklinza (Daclatasvir) For Treatment Of Certain Patients With Chronic Hepatitis C Genotypes 1, 3 And 4 10/16/2015 10:52:01 AM
Boehringer Ingelheim Release: National Institute for Clinical Excellence (NICE) Recommends VARGATEF (Nintedanib*) In Combination With Docetaxel As An Option For Patients With Non-Small Cell Lung Cancer Of Adenocarcinoma Histology Within Its Licensed Indication 6/3/2015 11:09:26 AM
National Institute for Clinical Excellence (NICE) Plans To Recommend A Technology To Hold Catheters In Place And Reduce Infection Risk 4/2/2015 8:49:42 AM
National Institute for Clinical Excellence (NICE) Recommends Olympus Medical's Transurethral Resection In Saline (Turis) System As The New Gold Standard For Transurethral Resection Of The Prostate (TURP) 2/25/2015 1:06:30 PM
National Institute for Clinical Excellence (NICE) Reverses October Decision And Approves Roche (RHHBY)'s Oncology Drug Gazyvaro 12/2/2014 9:15:09 AM
Alexion Pharmaceuticals Inc. (ALXN) Release: National Institute for Clinical Excellence (NICE) Issues Final Positive Recommendation For National Commissioning Of Soliris® (Eculizumab) For All Patients With aHUS In England 12/1/2014 12:09:06 PM
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG (NVS)'s Xolair To Treat Chronic Hives 11/19/2014 6:18:36 AM
12345678910...
//-->